Intedanib
CAS: 656247-17-5
Molecular Formula: C31H33N5O4
Molecular Weight: 539.62482
Product description:An oral dosing of triple tyrosine kinase inhibitors, targets including platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), also can inhibit the MAPK and Akt activation. At present is mainly used for tumor treatment, such as colorectal cancer, ovarian cancer and multiple myeloma. Studies of respiratory disorders centered advanced non-small cell lung cancer (NSCLC) and idiopathic pulmonary fibrosis (IPF) in clinical practice.
Disclaimer: the information on this website is from the internet for reference only. Please refer to the actual instructions attached to the product and the final interpretation is owned by the company.
for: Product Quotation ( Product suppliers),COA (Certificate of Analysis), New Sales
Promotion,New Products,And any other assistance.
After send online enquiry, we will reply you as soon as possible, if not get any response on time please contact us by Tel or Email.
1. Email: sales@aushealthingredients.com
2. Tel: +86 592 5365887
3. WhatsApp: +86 189 6516 2351
4. Send enquiry online: